Company / Tangible Book Value per Share
Arcus Biosciences, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$6.84
FY2025
5-year range
$6.34 / $12.93
FY2021-FY2025
Trend
+6.5%
vs FY2024
Sector context
#77 of 209
Health Care
What the data says
At $6.84, Arcus Biosciences, Inc.'s tangible book value per share ranks #77 of 209 in the Health Care sector. Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-39.56 in FY2017 to $12.93 in FY2021.
Based on SEC 10-K filings.
6.84 in FY2025 with a 5-year CAGR of +6.0%.
Improved from $6.34 to $6.84 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -1.2%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
#77 of 209 in Health CareTop 37% of 209This company $6.84 Sector average $93.47
▼
-92.7% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share increased 6.5% year-over-year.
- Ranks #77 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
- Lowest tangible book value per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -0.93 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.84 | +6.5% |
| FY2024 | $6.42 | +1.4% |
| FY2023 | $6.34 | -10.6% |
| FY2022 | $7.09 | -45.2% |
| FY2021 | $12.93 | +152.8% |
| FY2020 | $5.12 | +38.9% |
| FY2019 | $3.68 | +120.8% |
| FY2018 | -$17.68 | +55.3% |
| FY2017 | -$39.56 | -71.0% |
| FY2016 | -$23.14 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026